Casey Graziani

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2009

STA-9090 for Treatment of AML CML MDS and Myeloproliferative Disorders
March 2009 - February 2011
Myeloproliferative Disorders
Hematologic Neoplasms
Sta-9090



